Kazia Therapeutics Ltd (KZIA) is near the middle in its industry group according to InvestorsObserver. KZIA gets an overall rating of 49. That means it scores higher than 49 percent of stocks. Kazia Therapeutics Ltd gets a 45 rank in the Biotechnology industry. Biotechnology is number 16 out of 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Kazia Therapeutics Ltd Stock Today?
Kazia Therapeutics Ltd (KZIA) stock is higher by 72.94% while the S&P 500 is unchanged 0% as of 10:03 AM on Friday, Aug 7. KZIA is higher by $3.10 from the previous closing price of $4.25 on volume of 9,836,798 shares. Over the past year the S&P 500 is higher by 13.99% while KZIA is higher by 196.37%. KZIA lost -$1.23 per share the over the last 12 months.